Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), CONICET and Hospital de Clínicas Gral. José de San Martín, Universidad de Buenos Aires, Córdoba 2351 1er subsuelo, CP1120AAF, Ciudad de Buenos Aires, Argentina.
IDAS-CONICET, Departamento de Química, FCEFQYN, Universidad Nacional de Río Cuarto, Río Cuarto, Córdoba, Argentina.
BMC Cancer. 2021 May 13;21(1):547. doi: 10.1186/s12885-021-08286-6.
Photodynamic therapy (PDT) is an anticancer treatment that utilizes the interaction of light and a photosensitiser (PS), promoting tumour cell death mediated by generation of reactive oxygen species. In this study, we evaluated the in vitro photoactivity of four meso-substituted porphyrins and a porphyrin coupled to a fullerene.
The cell line employed was the LM3 mammary adenocarcinoma, and the PS with the best photokilling activity was administered to mice bearing the LM3 subcutaneously implanted adenocarcinoma. The TEMCP porphyrin and its analogue TEMCC chlorine contain four identical carbazoyl substituents at the meso positions of the tetrapyrrolic macrocycle and have A symmetry. The TAPP derivative also has A symmetry, and it is substituted at the meso positions by aminopropoxy groups. The DAPP molecule has ABAB symmetry with aminopropoxy and the trifluoromethyl substituents in trans positions. The TCP-C dyad is formed by a porphyrin unit covalently attached to the fullerene C.
The PSs are taken up by the cells with the following efficiency: TAPP> TEMCP = TEMCC > DAPP >TCP-C, and the amount of intracellular PS correlates fairly with the photodamage degree, but also the quantum yields of singlet oxygen influence the PDT outcome. TAPP, DAPP, TEMCC and TEMCP exhibit high photoactivity against LM3 mammary carcinoma cells, being TAPP the most active. After topical application of TAPP on the skin of mice bearing LM3 tumours, the molecule is localized mainly in the stratum corneum, and at a lower extent in hair follicles and sebaceous glands. Systemic administration of TAPP produces a tumour: normal skin ratio of 31.4, and high accumulation in intestine and lung.
The results suggest a potential use of topical TAPP for the treatment of actinic keratosis and skin adnexal neoplasms. In addition, selectivity for tumour tissue after systemic administration highlights the selectivity of and potentiality of TAPP as a new PS.
光动力疗法(PDT)是一种利用光和光敏剂(PS)相互作用的抗癌治疗方法,通过产生活性氧来促进肿瘤细胞死亡。在这项研究中,我们评估了四种介位取代卟啉和一种与富勒烯偶联的卟啉的体外光活性。
所使用的细胞系是 LM3 乳腺腺癌,并且将具有最佳光杀伤活性的 PS 施用于皮下植入 LM3 腺癌的小鼠。TEMCP 卟啉及其类似物 TEMCC 氯在四吡咯大环的介位上含有四个相同的咔唑取代基,具有 A 对称性。TAPP 衍生物也具有 A 对称性,并且在介位上被氨基丙氧基取代。DAPP 分子具有 ABAB 对称性,其反式位置上有氨基丙氧基和三氟甲基取代基。TCP-C 二聚体由卟啉单元与富勒烯 C 共价连接形成。
PS 被细胞摄取的效率如下:TAPP>TEMCP= TEMCC>DAPP>TCP-C,细胞内 PS 的量与光损伤程度相当,但单线态氧的量子产率也影响 PDT 结果。TAPP、DAPP、TEMCC 和 TEMCP 对 LM3 乳腺癌细胞表现出高的光活性,其中 TAPP 最活跃。在携带 LM3 肿瘤的小鼠皮肤表面应用 TAPP 后,该分子主要定位于角质层,在毛囊和皮脂腺中的程度较低。TAPP 的全身给药导致肿瘤:正常皮肤比值为 31.4,并在肠道和肺部有高蓄积。
结果表明,TAPP 局部应用于治疗光化性角化病和皮肤附属器肿瘤具有潜在用途。此外,全身给药后对肿瘤组织的选择性突出了 TAPP 作为新型 PS 的选择性和潜力。